The peptidomimetic Vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease

Overview of attention for article published in Science Translational Medicine, October 2015

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

news: 6 news outlets
blogs: 2 blogs
twitter: 17 X users

patent: 1 patent
facebook: 1 Facebook page

Readers on

mendeley: 85 Mendeley

So far, Altmetric has seen 6 news stories from 6 outlets.

New Drug Candidate is Therapeutic Option for Angiogenic Retinal Diseases

Drug Discovery and Development , 16 Oct 2015

A research team led by scientists at Beth Israel Deaconess Medical Center (BIDMC) and the University of New Mexico School of…

New drug candidate is promising therapeutic option for angiogenic retinal diseases

Today Topics , 15 Oct 2015

Research models show that a small peptide provents the overgrowth of blood vessels in the eye’s retina – and can be delivered…

New drug candidate is promising therapeutic option for angiogenic retinal diseases

Medical News Today, 15 Oct 2015

Research models show that a small peptide provents the overgrowth of blood vessels in the eye's retina - and can be delivered…

New drug candidate is promising therapeutic option for angiogenic retinal diseases

MedicalXpress, 14 Oct 2015

Home Ophthalmology October 14, 2015 October 14, 2015 A research team led by scientists at Beth Israel Deaconess Medical Center (B…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 2 additional news stories.